IO Biotech, Inc. (IOBT)
0.34
-0.02
(-5.69%)
USD |
NASDAQ |
Feb 20, 16:00
0.339
0.00 (0.00%)
Pre-Market: 20:00
IO Biotech Total Liabilities (Quarterly) : 39.04M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Moderna, Inc. | 3.688B |
| Plus Therapeutics, Inc. | 13.62M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.96M |
| Shareholders Equity (Quarterly) | 0.911M |
| Debt to Equity Ratio | 19.89 |
| Current Ratio | 2.011 |
| Net Debt Paydown Yield | -12.62% |